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Background: Wernicke’s encephalopathy (WE) and Korsakoff syndrome (KS) are under-
diagnosed. The DSM-5 has raised the diagnostic threshold by including KS in the major
neurocognitive disorders, which requires that the patient needs help in everyday activities.
Methods: We report clinical, neuropsychological, and radiological findings from a patient
who developed Wernicke-Korsakoff syndrome as a result of alcohol use and weight loss due
to major depression. We assess the diagnosis in the context of the scientific literature on KS
and according to the DSM-IV and the DSM-5.
Results: The patient developed ataxia during a period of weight loss, thus fulfilling current
diagnostic criteria of WE. WE was not diagnosed, but the patient partially improved after
parenteral thiamine treatment. However, memory problems became evident, and KS was
considered. In neuropsychological examination, the Logical Memory test and the Word List
test were abnormal, but the Verbal Pair Associates test was normal (Wechsler Memory Scale-
III). There were intrusions in the memory testing. The Wisconsin Card Sorting Test was
broadly impaired, but the other test of executive functions (difference between Trail Making
B and Trail Making A tests) was normal. There was atrophy of the mammillary bodies, the
thalamus, the cerebellum, and in the basal ganglia but not in the frontal lobes. Diffusion
tensor imaging showed damage in several tracts, including the uncinate fasciculi, the cinguli,
the fornix, and the corona radiata. The patient remained independent in everyday activities.
The patient can be diagnosed with KS according to the DSM-IV. According to the DSM-5,
the patient has major neurocognitive disorders.
Conclusions: Extensive memory testing is essential in the assessment of KS. Patients with
a history of WE and typical clinical, neuropsychological, and radiological KS findings may
be independent in everyday activities. Strict use of the DSM-5 may worsen the problem of
Wernicke-Korsakoff syndrome underdiagnosis by excluding clear KS cases that do not have
very severe functional impairment.
Keywords: alcoholism, depressive disorder, diffusion tensor imaging, Korsakoff syndrome,
neurocognitive disorders, Wernicke encephalopathy
Introduction
Thiamine deficiency can cause Wernicke’s encephalopathy (WE) and chronic
cognitive impairment, Korsakoff syndrome (KS).1–6 Alcohol abuse may result in
thiamine deficiency, but conditions unrelated to alcohol may cause malnutrition and
WE.7,8 Major depression with associated malnutrition may cause WE in non-
alcoholic patients9–19 or in the presence of alcohol abuse.20,21 KS has usually
been associated with alcoholic WE, and only recently it has been fully appreciated
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that also non-alcoholic WE can cause KS.4,6,8,22 To diag-
nose KS, the DSM-IV23 and DSM-524 require functional
impairment. Recently, the need for a comprehensive defi-
nition of KS has been noted.5
The core neuropsychological feature of KS is memory
impairment.2,3,5,25 Executive functions are impaired in alco-
holic KS,26–32 but they may be normal in non-alcoholic
KS.4,6,33 It has been recently reported that in alcoholic KS
the executive functions of shifting and updating are
affected, whereas inhibition may be spared.32
Conventional brain MRI of patients with neuropsycho-
logically documented non-alcoholic KS has been normal
in most cases, but frontal lobe and vermis atrophy have
been reported.4 Mammillary body (MB),34–38 central,38–41
vermis,40,41 and thalamic atrophy38,42 have been shown in
patients with cognitive symptoms following non-alcoholic
WE. Alcoholic KS is associated with brain atrophy in
cortical areas (particularly the frontal lobes), the MBs,
the amygdala, the thalamus, the hippocampus, the corpus
callosum, and the cerebellum.43,44
Diffusion Tensor Imaging (DTI) in KS has shown
abnormalities in frontotemporal tracts (uncinate, cingu-
lum), the fornix, the corpus callosum, the inferior long-
itudinal fasciculus, and the corona radiata.4,6,45,46
We describe Wernicke-Korsakoff syndrome (WKS) in
a patient with major depression and alcohol use disorder.
We describe neuropsychological, MRI, and DTI findings.




This male patient has had panic disorder and generalized
anxiety disorder since the age of 31, and major depression
since the age of 51. The patient had been using large
amounts of alcohol since his teen years. He had been on
long-term disability leave from his job as shop manager.
There was no history of traumatic brain injury or sub-
stance abuse other than alcohol.
At the age of 54, the patient’s depression worsened for
several months. He had poor appetite, and on several
occasions, he did not eat anything for two to three con-
secutive days. His weight dropped by 11 kg. During this
period of malnutrition, heavy alcohol use continued. The
patient was examined at the neurology outpatient clinic
because of pain and weakness in the lower limbs. There
was ataxia (wide-based walking, abnormal heel-shin test)
and tremor, muscle weakness, and muscle wasting of the
lower limbs. The patient walked with the help of a rollator.
Electromyoneurography and muscle biopsy of the lower
limbs were normal. Brain MRI showed some small diffuse
vascular lesions. Cerebrospinal fluid examination was nor-
mal except for a slightly elevated protein concentration.
Concentrations of gamma-glutamyl transpeptidase and
carbohydrate-deficient transferrin were elevated (76 U/L
and 48%, respectively), magnesium was low-normal (0.73
mmol/L, normal range 0.7–1.1), whereas the rest of the
blood tests (full blood count, sodium, potassium, calcium,
thyroid tests, creatine kinase, alkaline phosphatase, 25-
hydroxy vitamin D, ferritin, B12-vitamin, folate) were
normal. The diagnosis was leg weakness, and the patient
was advised to stop using alcohol.
Five months later the patient’s condition worsened, and
he was treated daily with thiamine intramuscularly for sev-
eral days as part of alcohol detoxification treatment. At the
same time, he considerably reduced his alcohol use. During
the next months, the lower limb symptoms partially
resolved, and the patient was able to walk independently.
However, one year after thiamine treatment, there was still
muscle weakness. The patient was able to walk a maximum
of four kilometers and could not bicycle uphill or run. He
complained of severe memory problems. He had difficulties
remembering past events, to which photographs helped. He
could not resume watching a recorded TV-program after
a 30-min break. There was a mild confabulation tendency
presenting as wrong recollection of conversations with
friends and relatives. The patient was living alone in his
own home and was independent in basic everyday activities.
The patient was evaluated for possible KS.
Neuropsychological assessment
The Vocabulary, Digit Symbol, Information, and Letter-
Number Sequencing subtests of the Wechsler Adult
Intelligence Scale-III (WAIS-III) were used to assess gen-
eral cognitive level, psychomotor speed, general knowl-
edge, and verbal working memory, respectively. General
attention and divided attention were tested with the Trail
Making A and B tests, respectively. We used the Wechsler
Memory Scale-III (WMS-III) to test memory. In testing
auditory/verbal memory, we used the Logical Memory
subtest and both word list subtests: the Word List test
that contains 12 unrelated words and the Verbal Pair
Associates (VPA) test that contains 8 word pairs. The
words of each pair are semantically unrelated, but it is
possible for the test subject to form associations that
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facilitate remembering.47 Testing of executive functions
comprised set shifting (Wisconsin Card Scoring Test/
WCST: number of categories achieved and number of
perseverative errors) and task switching (the score differ-
ence between Trail Making Tests B and A). Results at least
1.5 standard deviations (SDs) below the mean of norma-
tive values were considered abnormal for all tests except
the WCST, for which we used the –1 SD threshold sug-
gested in the test manual.48 Intrusions were defined as
false words and statements in the WMS-III.
DTI and conventional brain MRI
MRI and DTI were performed as previously described.4,6,49
Volumetric analysis was performed with the FDA-approved
cNeuro cMRI software (Combinostics, Finland).50 Brain
area volumes were measured in milliliters, and age- and
sex-adjusted volume z-scores were calculated based on the
comparison with controls. Z-scores ≤1 were considered
indicative of atrophy.43 The neocortical areas (frontal, tem-
poral, parietal, and occipital lobes separately) were evalu-
ated with the Pasquier’s global cortical atrophy (GCA)
scale.51 In addition, the MBs were manually outlined in
1.0 mm thick coronal reconstructions of 3D T1 images,
and their volume in milliliters was compared to 20 age-
and sex-matched controls.
In DTI analysis, fractional anisotropy (FA) values at
least 2 SDs smaller than those of 11 normal controls
matched for age and sex were considered abnormal. Prior
to the neuropsychological examination and the brain ima-
ging, the patient had greatly reduced his alcohol use for
three months, with normal values of carbohydrate-
deficient transferrin, erythrocyte mean corpuscular
volume, alanine aminotransferase, and gamma-glutamyl
transpeptidase. Medication at that time comprised quetia-
pine 75 mg in the evening and clonazepam 0.5 mg twice
per day for mood and anxiety symptoms.
Consent to participate
The study complied with the Declaration of Helsinki. The
patient gave written informed consent for the use of his
medical information in this publication. The study was
approved by the Satakunta Central Hospital. The Finnish
legislation does not require any further permissions.
Results
Abnormal memory results were found in tests of verbal
working memory, immediate and delayed verbal recall, and
in verbal and visual recognition (Table 1). The WMS-III
Word List subtest was abnormal, but the VPA test was
normal. There were two non-semantic intrusions in the
Table 1 Results of memory tests for a patient with Korsakoff syndrome
Cognitive domain Test Z-score
Working memory
Verbal WAIS-IIIa, Letter-Number Sequencing –1.67
Visual WMS-IIIb, Spatial Span –1
Episodic memory
Immediate recall
Verbal (logical) WMS-IIIb, Logical Memory I –1.67
Verbal (word list) WMS-IIIb, Verbal Paired Associates –0.67
Verbal (word list) WMS-IIIb, Word Lists –2.67
Visual WMS-IIIb, Visual Reproduction I –0.67
Delayed recall
Verbal (logical) WMS-IIIb, Logical memory II –2
Verbal (word list) WMS-IIIb, Verbal Paired Associates –1
Verbal (word list) WMS-IIIb, Word lists –2.67
Visual WMS-IIIb, Visual Reproduction II –0.67
Recognition
Verbal WMS-IIIb, Logical Memory II + Verbal
Paired Associates II –3
WMS-IIIb, Word Lists –3
Visual WMS-IIIb, Visual Recognition –2
Notes: Values of –1.5 or less (Z-score) are in bold. The patient’s results were compared to age-adjusted normative values. aWechsler Adult Intelligence Scale–III. bWechsler
Memory Scale-III.
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VPA test, and in the Logical Memory test, there were five
semantic and one non-semantic intrusion. In the other neu-
ropsychological tests (Table 2), abnormal results were found
in the Information subset of the WAIS-III and in the set-
shifting test of executive functions (WCST).
In brain volumetric analysis, atrophy changes were
found in the hypothalamus, the MBs, the left hippocam-
pus, the nucleus accumbens, the caudate, the pallidum, the
thalamus, and the vermis (Table 3). In addition, there was
general reduction of white-matter volume. CGA values
were well within normal limits. Abnormal FA-values
were found in several white matter tracts, including fron-
totemporal tracts (uncinate fasciculi, cingulum) (Table 4).
Figure 1 shows atrophy changes. Figure 2 shows a DTI
reconstruction of damaged white-matter tracts.
Discussion
We describe a patient with WKS caused by depression-
related malnourishment and alcohol. At the time of WE,
the patient had lost weight, and he was ataxic. Thus, the
WE diagnostic threshold of two out of four diagnostic
criteria (nutritional deficiency, ataxia, oculomotor abnorm-
alities, altered mental state or mild memory impairment)
proposed by Caine et al52 was reached.
Neuropsychological findings
The neuropsychological examination showed cognitive
impairment, memory being preferentially affected.
Logical memory and learning of unrelated words were
most severely affected, whereas learning of words that
can be semantically interconnected (VPA test) was normal.
Patients with KS may have partially preserved anterograde
semantic memory and be able to recruit associative
mechanisms.53 Preferential impairment in the VPA test
has been demonstrated in individuals with agenesis of
the corpus callosum with normal interhemispheric connec-
tivity being a prerequisite for a strong self-generated
semantic network that supports encoding.47 Interestingly,
the corpus callosum FA-values of our patient were normal.
We have recently shown that in patients with non-
alcoholic KS the logical memory test may be abnormal,
and the word list test may be normal and vice versa.6
Taken together with findings from the present patient,
these results corroborate our previous suggestion on the
need for a comprehensive neuropsychological evaluation
of patients with suspected KS.6 Among word list tests,
those containing unrelated words might have a better sen-
sitivity. Had this patient been tested only with the VPA test
or another word test that uses semantically related words,
it could have been erroneously concluded that there is no
memory impairment.
Similarly to previous studies, the patient made intru-
sions both in the logical memory test4,6 and the word list
test.4,6,54 This further supports the usefulness of intrusions
in examining patients with suspected KS.
In the WCST, both orbital prefrontal and dorsolateral
prefrontal functions were affected. This is in accordance
with previous findings in KS.27,32
In alcoholic KS, executive dysfunction is common,26–32
but in non-alcoholic KS, executive functions appear to be
largely preserved.4,6,33 There are several possible explana-
tions for this discrepancy. Executive dysfunction in alco-
holic KS could be due to a toxic effect of alcohol to the
frontal lobes,26 and coexistence with thiamine-deficiency
Table 2 Results of neuropsychological tests other than memory for a patient with Korsakoff syndrome
Cognitive domain Test Z–score
General cognitive level Vocabulary subset (WAIS–IIIa) –0.67
General knowledge Information subset (WAIS–IIIa) –2.33
General attention Trail Making Test A 0.82
Divided attention Trail Making Test B 0
Psychomotor speed Digit Symbol subset (WAIS–IIIa) –1
Executive functions I (set shifting)
Orbital prefrontal functions WCSTb, number of perseverative errors –3
Dorsolateral prefrontal functions WCSTb, number of categories completed –1.41
Executive functions II (task switching) Trail B – Trail A score –0.82
Notes: Z-score values ≤–1.5 (≤–1 for the WCST test) are in bold. The patient’s results were compared to age-adjusted normative values. aWechsler Adult Intelligence
Scale–III. bWisconsin Card Scoring Test.
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induced memory impairment may be incidental. Another
possible explanation is a selection bias, due to recruitment
of KS study subjects from nursing facilities. Residents of
nursing facilities are very probable to have executive dys-
function (since they cannot live independent lives). Van
Oort and Kessels have shown that KS patients residing in
nursing facilities have executive dysfunction,28 and Bowden
has noted that studies of alcoholic KS are biased toward
including more severe cases.55 In contrast, our previously
reported patients with non-alcoholic KS and normal or
minimally impaired executive functions were identified by
screening psychiatric outpatients for previously undiag-
nosed WE.4,6 Alternatively, repeated episodes of WE may
cause executive dysfunction, and patients with long-term
alcoholism are more probable to have repeated WE epi-
sodes compared to non-alcoholic WE patients. However, we
have recently reported on a patient with two separate WE
episodes caused by hyperemesis gravidarum who developed
non-alcoholic KS without executive dysfunction.4
One of the tests we used to assess executive functions
was the WCST. Similarly to previous studies.25,27,56,57
both the number of categories completed and the number
of perseveration errors were abnormal. This dual abnorm-
ality may differentiate alcoholic KS patients from patients
with other causes of organic amnesia.56,57 Although fre-
quently associated with frontal lobe atrophy, abnormal







Brain stem 18.2 29 –0.55
Hemispheric gray matter total 598 56 0.15
Hemispheric gray matter right 300 57 0.18
Hemispheric gray matter left 298 54 0.10
Hemispheric white matter 404 7 –1.48
Cerebrospinal fluid 49.2 94 1.55
Entorhinal area, right 2.71 85 1.04
Entorhinal area, left 2.25 51 0.03
Hippocampus, right 3.67 27 –0.61
Hippocampus, left 3.22 10 –1.28
Amygdala, right 1.17 47 –0.08
Amygdala, left 1.13 32 –0.47
Nucleus accumbens, right 0.34 4 –1.75
Nucleus accumbens, left 0.33 1 –2.33
Caudate nucleus, right 2.79 7 –1.48
Caudate nucleus, left 2.65 3 –1.88
Pallidum, right 1.29 9 –1.34
Pallidum, left 1.29 12 –1.17
Putamen, right 4.74 66 0.41
Putamen, left 4.63 48 –0.05
Thalamus, right 7.13 7 –1.48
Thalamus, left 7.32 8 –1.41
Hypothalamus, right 4.17 7 –1.48
Hypothalamus, left 4.21 4 –1.75
Cerebellar vermal lobules I - V 3.41 10 –1.28
Cerebellar vermal lobules VI -VII 1.61 13 –1.13
Cerebellar vermal lobules VIII - X 2.19 9 –1.34
Cerebellum exterior, right 49 23 –0.74
Cerebellum exterior, left 49.8 36 –0.36
Cerebellum white matter, right 11.7 15 –1.04
Cerebellum white matter, left 11.9 23 –0.74
Mammillary bodies (right + left) 112 9 –1.32
Notes: The volume of the mammillary bodies was compared to 20 healthy con-
trols. For the rest of the brain areas, the cNeuro cMRI software was used. Values
<–1 (for gray or white matter brain areas) and >1 (for CSF areas) are in bold.
Table 4 Fractional anisotropy (FA) values from diffusion tensor
imaging in a patient with Korsakoff syndrome
White matter tract Tractography
threshold
Z-score
Corpus callosum genu 0.50/27 –1.2
Corpus callosum body 0.50/27 –1.1
Corpus callosum splenium 0.50/27 –0.8
Superior cingulum, right 0.15/27 –2.5
Superior cingulum, left 0.15/27 –2.0
Inferior cingulum, right 0.15/27 –2.2
Inferior cingulum, left 0.15/27 –2.3
Subgenual cingulum, right 0.15/27 –2.8
Subgenual cingulum, left 0.15/27 –2.5
Uncinate fasciculus, right 0.15/27 –2.2




Superior longitudinal fasciculus, left 0.15/27 –1.2
Inferior longitudinal fasciculus, right 0.15/27 –3.1
Inferior longitudinal fasciculus, left 0.15/27 –2.1







Anterior corona radiata, right 0.15/27 –2.0




Frontostriatal projection fibers, left 0.15/27 –1.9
Mesencephalic projections, right 0.30/27 –1.5
Mesencephalic projections, left 0.30/27 −0.3
Fornix, right 0.15/40 –1.8
Fornix, left 0.15/40 –2.0
Descending fornix, right 0.15/40 –2.2
Descending fornix, left 0.15/40 –1.7
Notes: Z-scores represent the difference from the mean of controls with one
standard deviation as the unit. Values ≤–2 are in bold.
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results in the WCST may also be due to lesions in the
thalamus, the basal ganglia, the cerebellum, and frontos-
triatal white matter tracts.58 The thalamus, the basal gang-
lia, and the cerebellum, but not the frontal lobes, showed
signs of atrophy in our patient. The frontostriatal tracts had
reduced FA-values but below the – 2 SD threshold we
used. Similarly to previous studies,4,6,30 the task switching
test (Trail B – Trail A score) was normal.
Neuroimaging findings
MRI showed more than 1 SD volume reduction in the
thalamus, the MBs, and the vermis, as severe as in typical
alcoholic KS.43 Atrophy was also found in the basal gang-
lia, a brain area that can be affected in WKS.59 However,
contrary to findings in patients with alcohol use disorder,60
there was no cortical atrophy. This underscores the
importance of thiamine deficiency in the development of
KS in the present patient as opposed to a direct effect of
alcohol.
DTI showed extensive damage in white matter tracts.
Similarly to previous KS studies, damage was shown in
the Papez circuit (fornix),46 frontotemporal tracts (uncinate
fasciculus, cingulum),4,6 the inferior longitudinal
fasciculus,4 and the anterior corona radiata.4,45 There was
also damage in the superior longitudinal fasciculus, which
has been recently shown to be affected in alcoholic men.61
Together with results from previous studies,4,6,45,46 our
results support the importance of DTI in exploring brain
damage in WKS. Damage in the uncinate fasciculus and
the temporal cingulum supports our previous suggestion
on the importance of frontotemporal tract involvement in
WKS.6
KS diagnosis
The clinical history and the results of the neuropsycholo-
gical and radiological examinations support the diagnosis
of KS. However, when considering functional impairment,
the patient can be diagnosed with KS according to the
DSM-IV but not according to the DSM-5.
The DSM-IV mentions KS as alcohol-induced persist-
ing amnestic disorder due to thiamine deficiency. The
DSM-5 changed the classification of neurocognitive dis-
orders (NCDs) by introducing a baseline distinction
between major and mild NCDs.24 A defining characteristic
of major NCD is inability to function independently in
everyday life. The DSM-5 mentions thiamine deficiency
and alcohol as independent causes of major and mild
Figure 1 MRI sagittal image showing mild mammillary body atrophy (white arrow)







Figure 2 Tractograms of the patient (A, B, C) and a control subject (D, E, F). The control subject’s tractograms are of average size. The superior cingulum is in blue, the
inferior cingulum is in green, and the corpus callosum is in red (A, B, D, E). The fasciculus uncinatus is in magenta (C, F). The patients’ tractograms (except for the corpus
callosum) are markedly smaller than the tractograms of the control. R, Right side, L, Left side.
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NCD. KS is mentioned as alcohol-induced amnestic con-
fabulatory major NCD with prominent amnesia and
a tendency to confabulate.
Therefore, the DSM-5 has raised the threshold to diag-
nose KS. A person with memory impairment that cannot
work but is independent in everyday life could have been
diagnosed with KS in DSM-IV but cannot be diagnosed
with KS with DSM-5. Interestingly, the other NCDs may
manifest both as major and mild, and KS appears to be the
only exception.
The DSM-5 inappropriately restricts the use of the term
KS to cases were the memory impairment was caused by
alcohol and the patient confabulates (“alcohol-induced
amnestic confabulatory NCD”). However, it has been
shown that KS may occur as a result of non-alcoholic
WE.4,6,8,22,33 Spontaneous confabulations are uncommon
in chronic KS.2
As illustrated by the present patient, patients with
partially preserved functioning after WE may fit diagnos-
tically within the current clinical and research framework
of KS. It is possible to use the DSM-5 terms mild NCD
due to a medical disorder (thiamine deficiency), mild NCD
due to alcohol, or (as in the current patient) use both
diagnoses.
According to the DSM-5, neuropsychological test
results between –1 and –2 SDs below the normative
mean are associated with mild NCD, whereas more devi-
ant test results (at least – 2 SDs below the normative
mean) suggest major NCD. Our patient had test results
compatible with major NCD on most abnormal memory
test results.
Three considerations further support the use of the KS
diagnosis for patients with DSM-5 mild NCD. First, the
DSM-5 encourages a disorder conceptualization based on
empirical validation of biological determinants.
Researchers and clinicians are encouraged to use the
Alzheimer’s disease diagnosis instead of Mild Cognitive
Impairment for patients with cerebrospinal fluid, positron-
emission tomography, and neuropsychological findings
compatible with Alzheimer’s disease, even with not severe
functional impairment. Second, thiamine deficiency can
vary in severity and duration, and so can vary the ade-
quacy of thiamine treatment. Presumably, the ensuing
brain damage and functional impairment will vary in
severity. Mild memory impairment after WE has been
mentioned in many previous reports..34,62–77 We have pre-
viously reported on a patient with non-alcoholic KS and
atypical neuropsychological presentation that also
presented with mild NCD.6 Third, WKS is greatly under-
diagnosed, particularly in non-alcoholic patients.2,4,6,7
Given the devastating effects of undiagnosed and untreated
WKS, it is not wise to raise the diagnostic threshold in the
absence of supporting empirical evidence.
Major depression may cause cognitive impairment, but
comorbid affective disorder does not exacerbate the effects
of alcohol use on cognition.75 Chronic alcoholism may
cause cognitive problems, but abstinence is associated
with substantial recovery.76 The present patient presented
memory complaints only after the WE. The presence of
intrusions in memory testing is suggestive of organic
memory impairment.4,6 Deficiency of other micronutrients
may have contributed to the cognitive problems.77
Other clinical aspects
The patient presented with severe muscle weakness that
partially improved after thiamine treatment. Partially
improved muscle weakness has been previously described
in WKS.6,74,78
The underdiagnosis of KS has been attributed to
patients being diagnosed with alcoholic dementia when
the cognitive impairment has been in fact caused by thia-
mine deficiency.55 Psychiatric patients with non-alcoholic
KS are another underdiagnosed group.4,6 Our results,
together with results from our previous reports,4,6 may
help identify KS patient who despite clear memory impair-
ment live relatively independent lives.
The patient in the present report developed thiamine
deficiency as a result of psychiatric disease (major depres-
sion) and alcohol use. Major depression is associated with
weight loss,24 and comorbid alcohol use disorder is
common.79 Thus, depressed patients may be at high risk for
WKS. To our knowledge, there are 12 previous reports of
major depression causing malnutrition and WE.9,10,12–18,20,21
Two of these patients had concomitant alcohol use
disorder.20,21 In our patient, treatment with parenteral thia-
mine was delayed, which possibly resulted in long-term
memory impairment and muscle weakness. This underlines
the importance of early recognition and treatment of WE but
also the usefulness of routine administration of parenteral
thiamine in alcohol detoxification.80
The continuity theory claims that alcohol affects mem-
ory along a continuum with KS patients being gravely
impaired.81 However, as the present report illustates, it is
not possible to know whether a patient with clear but not
debilitating memory impairment has mild KS or is an
“uncomplicated alcoholic”.55 This supports the notion
Dovepress Nikolakaros et al
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that previous results in support of the continuity theory
may instead reflect a continuum of memory impairment
caused by thiamine deficiency.5
We have previously reported on six psychiatric
patients with KS and previously undiagnosed non-
alcoholic WE, which were identified through systema-
tic consideration of WKS in psychiatric patients with
prominent memory complaints.4,6 The present patient
extends the usefulness of this clinical approach to
patients with previously undiagnosed WE of mixed
etiology (alcoholic and psychiatric).
Limitations
Our study has several limitations. Data come from only
one patient. Larger studies are needed to further explore
imaging and neuropsychological features of relatively
mild WKS. We assessed executive functions with only
two tests. A more thorough examination could have
provided a more complete picture of impairment and
preserved skills. We did not examine the frontocerebel-
lar tracts that may be affected in WKS.45,82
Conclusions
In summary, we present a patient that developed WKS
as a result of depression and alcohol use. The patient’s
chronic memory impairment has compromised his
working ability, but he does not need assistance in
everyday life. The patient can be diagnosed with KS
according to the DSM-IV but not according to the
DSM-5. However, all the core neuropsychological and
radiological findings of KS were present. Strict use of
the DSM-5 in evaluating patients suspected of having
KS may lead to underdiagnosis. Finally, the memory
testing of patients with suspected KS should be com-
prehensive and include word list tests containing
semantically unrelated items.
Abbreviation list
DTI, diffusion tensor imaging; FA, fractional anisotropy;
KS, Korsakoff syndrome; MB, mammillary body; NCD,
neurocognitive disorder; SD, standard deviation; VPA,
verbal pair associates; WCST, Wisconsin Card Scoring
Test; WE, Wernicke’s encephalopathy; WKS, Wernicke-
Korsakoff syndrome; WMS-III, Wechsler memory scale-
III.
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